Европска Унија -
Дански -
EMA (European Medicines Agency)
benlysta
glaxosmithkline (ireland) limited - belimumab - lupus erythematosus, systemisk - immunosuppressiva - benlysta er angivet som add-on terapi til patienter i alderen 5 år og ældre med en aktiv, autoantibody positive systemisk lupus erythematosus (sle) med en høj grad af sygdommens aktivitet (e. positive anti-dsdna og lave supplement), på trods af standard-terapi. benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.
Европска Унија -
Дански -
EMA (European Medicines Agency)
saphnelo
astrazeneca ab - anifrolumab - lupus erythematosus, systemisk - immunosuppressiva - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.
Европска Унија -
Дански -
EMA (European Medicines Agency)
lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - immunosuppressiva - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
Данска -
Дански -
Lægemiddelstyrelsen (Danish Medicines Agency)
femicept 150 mkg+30 mkg overtrukne tabletter
campuspharma ab - ethinylestradiol, levonorgestrel - overtrukne tabletter - 150 mkg+30 mkg